切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2016, Vol. 10 ›› Issue (04) : 294 -297. doi: 10.3877/cma.j.issn.1674-0793.2016.04.015

所属专题: 文献

论著

多指标联合检测在肝癌筛查中的可行性研究
孙浩1, 季明芳2, 张常华3, 胡泽民2, 冯谦谨2, 余元龙2,()   
  1. 1. 510800 广州,中山大学附属第一医院普外科;528400 中山市人民医院肝胆外科
    2. 528400 中山市人民医院肝胆外科
    3. 510800 广州,中山大学附属第一医院普外科
  • 收稿日期:2016-06-10 出版日期:2016-08-01
  • 通信作者: 余元龙
  • 基金资助:
    中央补助地方公共卫生专项资金癌症早诊早治资助项目(2012)

Multi-index joint detection feasibility study for hepatocacinoma screening

Hao Sun1, Mingfang Ji2, Changhua Zhang3, Zemin Hu2, Qianjin Feng2, Yuanlong Yu2,()   

  1. 1. Department of General Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China; Department of Hepatobiliary Surgery, Zhongshan People's Hospital, Guangzhou 528400, China
    2. Department of Hepatobiliary Surgery, Zhongshan People's Hospital, Guangzhou 528400, China
    3. Department of General Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2016-06-10 Published:2016-08-01
  • Corresponding author: Yuanlong Yu
  • About author:
    Corresponding author: Yu Yuanlong, Email:
引用本文:

孙浩, 季明芳, 张常华, 胡泽民, 冯谦谨, 余元龙. 多指标联合检测在肝癌筛查中的可行性研究[J/OL]. 中华普通外科学文献(电子版), 2016, 10(04): 294-297.

Hao Sun, Mingfang Ji, Changhua Zhang, Zemin Hu, Qianjin Feng, Yuanlong Yu. Multi-index joint detection feasibility study for hepatocacinoma screening[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2016, 10(04): 294-297.

目的

探索乙肝表面抗原(HBsAg)、抗丙型肝炎病毒(Anti-HCV)、HBV-DNA和甲胎蛋白(AFP)多指标联合检测在肝癌筛查中的可行性。

方法

选择2014年5月至2015年10月中山市人民医院肝胆外科收治的原发性肝癌患者139例为病例组。在2012年中山市肝癌筛查队列人群中按年龄±5和性别以4∶1与病例组随机匹配,选择对照样本556人纳入对照组;采用酶联免疫吸附(ELISA)法检测研究对象血清标本中HBsAg、Anti-HCV和AFP;运用PCR体外扩增荧光定量(FQ-PCR)法检测血清HBV-DNA;比较两组四项指标的阳性率,探讨单指标和多指标联合检测在肝癌筛查中的敏感度、特异度和漏检率。

结果

单一指标筛查时,AFP敏感度最高,其次为HBsAg。以HBsAg为主体的联合筛查,不同指标联合筛查有不同的敏感度和漏检率,以HBsAg、Anti-HCV、AFP联合HBV-DNA的敏感度最高,漏检率最低;其次为HBsAg、AFP联合HBV-DNA;再次为HBsAg、Anti-HCV联合AFP。

结论

联合检测HBsAg、Anti-HCV和AFP进行初筛,可以极大地提高肝癌高危人群的早期筛查效果。

Objective

To explore the feasibility of multi-index joint detection of hepatitis B surface antigen (HBsAg), Anti-hepatitis C virus (Anti-HCV), HBV-DNA and alpha-fetoprotein (AFP) for screening liver cancer.

Methods

From May 2014 to October 2015, one hundred and thirty-nine cases with hepatocellular carcinoma in Zhongshan People's Hospital were selected as case group. At the same time, 556 cases were chosen as control group by age±5 and gender in the ratio of 4:1 randomly matched group cases in Zhongshan Gity liver cancer screening research in 2012. HBsAg, Anti-HCV and AFP in serum were detected by enzyme-linked immunosorbent assay (ELISA). FQ-PCR method was used to detect HBV-DNA in serum samples. Positive rate of single index indicators in the two groups, and the sensitivity, specificity, and false negative rate of multiple-index combined detection were explored in hepatocarcinoma screening.

Results

AFP sensitivity was the best for single index screening, followed by HBsAg. When HBsAg was used as the main body of the combined screening, the combination of different indicators had different sensitivity, with the miss rate of HBsAg, Anti-HCV, and AFP joined by HBV-DNA having the best sensitivity and the lowest miss rate; followed by HBsAg, AFP joined by HBV-DNA; and by HBsAg, Anti-HCV joined by AFP.

Conclusion

Combined detection of HBsAg, Anti-HCV and AFP screening can improve the early screening effect of high-risk liver cancer patients.

表1 两组肝癌筛查人群的指标检测阳性结果[例/人(%)]
表2 两组HBsAg(-)人群中其他指标检测阳性结果[例/人(%)]
表3 四种指标单独用于肝癌筛查的真实性评价[例/人(%)]
表4 四种指标不同联合检测方案用于肝癌筛查的真实性评价
1
余元龙,魏矿荣,季明芳,等.中山市恶性肿瘤发病地域分布研究[M].中山:广东人民出版社, 2012.
2
梁智恒,彭侠彪,岑惠珊,等.广东省中山市1970~2010年肝癌发病概况[J].中国肿瘤, 2015, 24(8): 631-637.
3
梁智恒,彭侠彪,岑惠珊,等.广东省中山市1970~2010年肝癌死亡概况[J].中国肿瘤, 2015, 24(8): 638-644.
4
Flores A,Marrero JA. Emerging trends in hepatocellular carcino-ma: focus on diagnosis and therapeutics[J]. Clin Med Insights On-col, 2014, 8: 71-76.
5
Abe K,Edamoto Y,Park YN, et al. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions[J]. Hepatology, 1998, 28(2): 568-572.
6
Hall AJ,Wild CP. Liver cancer in low and middle income coun-tries[J]. BMJ, 2003, 326(7397): 994-995.
7
Wong RJ,Waknuk J,Valenzuela A, et al. Primary surgical resec-tion versus liver transplantation for transplant eligible hepatocel-lular carcinoma patients[J]. Dig Dis Sic, 2014, 59(1): 183-191.
8
Lencioni R,Cioni D,Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percuta-neous image-guided radio frequency ablation [J]. Radiology, 2005, 234(3): 961-967.
9
Llovet JM. Updated treatment approach to hepatocellular carcino-ma[J]. Gastroenterology, 2005, 40(3): 225-235.
10
癌症早诊早治项目专家委员会.癌症早诊早治项目技术方案(2011年版)[M].北京:人民卫生出版社, 2011: 110-143.
11
俞霞,季明芳,程伟民,等.中山市小榄镇肝癌高发现场筛查评估及问题分析[J].肿瘤防治研究, 2016, 43(4): 287-290.
12
姜世强,柳青. Logistic回归模型在早期鼻咽癌多指标联合辅助诊断实验的应用[J].癌症, 2009, 28(2): 213-216.
13
Barve A,Khan R,Marsano L, et al. Treatment of alcoholic liver disease[J]. Ann Hepatol, 2008, 7(1): 5-15.
14
Fan JG,Zhu J,Li XJ, et al. Prevalence of and risk factors for fat-ty liver in a general population of Shanghai, China[J]. J Hepatol, 2005, 43(3): 508-514.
15
Tateishi R,Yoshida H,Matsuyama Y, et al. Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic re-view[J]. Hepatol Int, 2008, 2(1): 17-30.
16
Thomson SJ,Westlake S,Rahman TM, et al. Chronic liver disease-an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcohol-ic liver disease[J]. Alcohol Alcohol, 2008, 43(4): 416-422.
17
Shim J,Kim BH,Kim NH, et al. Clinical features of HBsAg-neg-ative but anti-HBc-positive hepatocellular carcinoma in a hepati-tis B virus endemic area[J]. J Gastroenterol Hepatol, 2005, 20(5): 746-751.
[1] 徐婷婷, 詹泳池, 王晓东, 刘兴会. 电子胎心监测结果出现正弦波形的胎母输血综合征围生期结局分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 382-389.
[2] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[5] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[6] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[7] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[8] 林小勇, 张兰霞, 曾庆劲, 贺需旗, 谭雷, 郭光辉, 龙颖琳, 李凯, 吴宇轩. 负压抽吸活检针在肝困难病灶活检中的初步应用研究[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 694-698.
[9] 雷永琪, 刘新阳, 杨黎渝, 铁学宏, 俞星新, 耿志达, 刘雨, 陈政良, 惠鹏, 梁英健. 肝脏血管周上皮样细胞肿瘤合并贫血一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 710-718.
[10] 欧阳佳裕, 李刚, 贺露瑶, 罗娜. 双层探测器光谱CT在早期原发性肝癌中的诊断价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 557-561.
[11] 王凯飞, 牟怡平, 李晓辉, 王瑞涛, 侯惠莲, 张月浪. 原发性肝平滑肌肉瘤临床病理特征及疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 357-362.
[12] 陈志坚, 俞建达, 池小斌, 吕立志, 陈永标. 三维可视化技术在腹腔镜肝巨大肿瘤切除中的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 302-307.
[13] 黄俊豪, 陈宗杰, 胡添松. 血小板相关参数对肝内胆管细胞癌根治性切除患者预后预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 308-312.
[14] 马欢欢, 马晨辉, 邓小博, 王博方, 何普毅, 王云鹏, 许博, 俞荣, 王娜, 陈昊. 肝癌实体瘤治疗疗效评价系统的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 377-383.
[15] 张婵, 吕瑶, 张小燕, 张鸣青. 不同时机局部神经阻滞在开腹肝切除中的镇痛效果比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 189-194.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?